L19TNF is an experimental antibody-cytokine fusion protein that targets tumors. It’s designed to work alongside standard cancer treatments to help fight glioblastoma, which is a type of brain cancer. This medication aims to specifically target tumor tissues while minimizing effects on healthy cells.

Temozolomide is a chemotherapy medication used to treat certain types of brain tumors. It works by stopping or slowing the growth of cancer cells. It’s commonly used as a standard treatment for glioblastoma and is taken orally.

Chemoradiotherapy is a combined treatment approach that uses both chemotherapy and radiation therapy together. The radiation therapy uses high-energy rays to target and destroy cancer cells, while the chemotherapy medication helps make the cancer cells more sensitive to the radiation treatment.

Glioblastoma – A type of brain tumor that develops from star-shaped cells called astrocytes in the brain and spinal cord. It forms a mass of abnormal cells that grows in the brain tissue, typically in the cerebral hemispheres. The tumor can grow rapidly, creating pressure within the brain and interfering with normal brain function. Glioblastoma can cause various symptoms depending on its location, including headaches, seizures, confusion, and changes in vision or speech. As the tumor grows, it forms its own blood vessel network to maintain its growth.